Innate immunity in the central nervous system.
暂无分享,去创建一个
[1] R. Ransohoff,et al. Heterogeneity of CNS myeloid cells and their roles in neurodegeneration , 2011, Nature Neuroscience.
[2] J. McClure,et al. Functional Duality of Astrocytes in Myelination , 2011, The Journal of Neuroscience.
[3] R. Bainton,et al. Physiologic and anatomic characterization of the brain surface glia barrier of Drosophila , 2011, Glia.
[4] F. Rossi,et al. Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool , 2011, Nature Neuroscience.
[5] Simon C. Potter,et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis , 2011, Nature.
[6] Alberto Mantovani,et al. Neutrophils in the activation and regulation of innate and adaptive immunity , 2011, Nature Reviews Immunology.
[7] F. Safavi,et al. Kit (W-sh) Mice Develop Earlier and More Severe Experimental Autoimmune Encephalomyelitis Due to Absence of Immune Suppression , 2011, The Journal of Immunology.
[8] A. Waisman,et al. Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens. , 2011, Immunity.
[9] B. Becher,et al. RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation , 2011, Nature Immunology.
[10] James J. Campbell,et al. Epicutaneous challenge of orally immunized mice redirects antigen-specific gut-homing T cells to the skin. , 2011, The Journal of clinical investigation.
[11] S. Masters,et al. Disease-associated amyloid and misfolded protein aggregates activate the inflammasome. , 2011, Trends in molecular medicine.
[12] C. Gabay,et al. Interleukin-33 biology with potential insights into human diseases , 2011, Nature Reviews Rheumatology.
[13] N. Miyasaka,et al. Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis , 2011, Annals of the rheumatic diseases.
[14] H. Kettenmann,et al. Physiology of microglia. , 2011, Physiological reviews.
[15] B. Becher,et al. CD11c-expressing cells reside in the juxtavascular parenchyma and extend processes into the glia limitans of the mouse nervous system , 2011, Acta Neuropathologica.
[16] M. E. Walker,et al. Cutting Edge: Mast Cells Regulate Disease Severity in a Relapsing–Remitting Model of Multiple Sclerosis , 2011, The Journal of Immunology.
[17] M. Colombo,et al. Exacerbated experimental autoimmune encephalomyelitis in mast-cell-deficient KitW-sh/W-sh mice , 2011, Laboratory Investigation.
[18] P. Sansonetti,et al. NLR functions beyond pathogen recognition , 2011, Nature Immunology.
[19] P. Magistretti,et al. Astrocyte–neuron metabolic relationships: for better and for worse , 2011, Trends in Neurosciences.
[20] David W. Holman,et al. The blood-brain barrier, chemokines and multiple sclerosis. , 2011, Biochimica et biophysica acta.
[21] J. Grutzendler,et al. CX3CR1 in Microglia Regulates Brain Amyloid Deposition through Selective Protofibrillar Amyloid-β Phagocytosis , 2010, The Journal of Neuroscience.
[22] N. Borregaard,et al. Neutrophils, from marrow to microbes. , 2010, Immunity.
[23] D. Attwell,et al. Glial and neuronal control of brain blood flow , 2010, Nature.
[24] K. Nave. Myelination and support of axonal integrity by glia , 2010, Nature.
[25] R. Ransohoff,et al. The myeloid cells of the central nervous system parenchyma , 2010, Nature.
[26] Ben A. Barres,et al. Regulation of synaptic connectivity by glia , 2010, Nature.
[27] Kerri M. Smith. Neuroscience: Settling the great glia debate , 2010, Nature.
[28] F. Ginhoux,et al. Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages , 2010, Science.
[29] R. Ransohoff,et al. CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models. , 2010, The American journal of pathology.
[30] T. Abe,et al. IL-33 is a crucial amplifier of innate rather than acquired immunity , 2010, Proceedings of the National Academy of Sciences.
[31] R. Ransohoff,et al. Regulation of Tau Pathology by the Microglial Fractalkine Receptor , 2010, Neuron.
[32] P. Crack,et al. Neural injury following stroke: are Toll‐like receptors the link between the immune system and the CNS? , 2010, British journal of pharmacology.
[33] S. Chensue,et al. EAE mediated by a non‐IFN‐γ/non‐IL‐17 pathway , 2010, European journal of immunology.
[34] Denis Gris,et al. NLRP3 Plays a Critical Role in the Development of Experimental Autoimmune Encephalomyelitis by Mediating Th1 and Th17 Responses , 2010, The Journal of Immunology.
[35] R. Ransohoff,et al. Myelin Repair Is Accelerated by Inactivating CXCR2 on Nonhematopoietic Cells , 2010, The Journal of Neuroscience.
[36] M. Tsai,et al. Mast cells in allergy and infection: Versatile effector and regulatory cells in innate and adaptive immunity , 2010, European journal of immunology.
[37] Martine M. Mirrione,et al. Microglial ablation and lipopolysaccharide preconditioning affects pilocarpine-induced seizures in mice , 2010, Neurobiology of Disease.
[38] M. E. Walker,et al. Meningeal Mast Cells Affect Early T Cell Central Nervous System Infiltration and Blood-Brain Barrier Integrity through TNF: A Role for Neutrophil Recruitment? , 2010, The Journal of Immunology.
[39] Anirban Basu,et al. Inflammasome signaling at the heart of central nervous system pathology , 2010, Journal of neuroscience research.
[40] H. Pfister,et al. New understandings on the pathophysiology of bacterial meningitis , 2010, Current opinion in infectious diseases.
[41] S. Abraham,et al. Mast cell-orchestrated immunity to pathogens , 2010, Nature Reviews Immunology.
[42] D. Hume,et al. Unravelling mononuclear phagocyte heterogeneity , 2010, Nature Reviews Immunology.
[43] S. Akira,et al. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors , 2010, Nature Immunology.
[44] G. Graham,et al. Astrocytes modulate the chemokine network in a pathogen-specific manner. , 2010, Biochemical and biophysical research communications.
[45] Richard M. Page,et al. Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease , 2010, Nature Neuroscience.
[46] T. Möller,et al. Microglia in ischemic brain injury. , 2010, Future neurology.
[47] M. Karjalainen‐Lindsberg,et al. Mast Cells as Early Responders in the Regulation of Acute Blood–Brain Barrier Changes after Cerebral Ischemia and Hemorrhage , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[48] R. Fairchild,et al. Role of TNFα in Early Chemokine Production and Leukocyte Infiltration into Heart Allografts , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[49] W. Junger,et al. Circulating Mitochondrial DAMPs Cause Inflammatory Responses to Injury , 2009, Nature.
[50] C. Glass,et al. The nuclear receptor PPARγ selectively inhibits Th17 differentiation in a T cell–intrinsic fashion and suppresses CNS autoimmunity , 2009, The Journal of Experimental Medicine.
[51] D. Golenbock,et al. Inflammasomes: too big to miss. , 2009, The Journal of clinical investigation.
[52] O. Kirmi,et al. Anatomy and imaging of the normal meninges. , 2009, Seminars in ultrasound, CT, and MR.
[53] O. Kirmi,et al. Imaging of the meninges and the extra-axial spaces. , 2009, Seminars in ultrasound, CT, and MR.
[54] Pillars article: fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell-deficient w/wv mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells. , 2009, Journal of immunology.
[55] H. Wekerle,et al. Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions , 2009, Nature.
[56] A. Volterra,et al. Astrocytic dysfunction: Insights on the role in neurodegeneration , 2009, Brain Research Bulletin.
[57] Michael Famulok,et al. The nuclear receptor PPARγ selectively inhibits Th17 differentiation in a T cell–intrinsic fashion and suppresses CNS autoimmunity , 2009, The Journal of experimental medicine.
[58] S. Lehnardt,et al. Innate immunity and neuroinflammation in the CNS: The role of microglia in Toll‐like receptor‐mediated neuronal injury , 2009, Glia.
[59] V. Shestopalov,et al. Inactivation of astroglial NF‐κB promotes survival of retinal neurons following ischemic injury , 2009, The European journal of neuroscience.
[60] Andrés Hurtado,et al. Transgenic inhibition of astroglial NF‐κB leads to increased axonal sparing and sprouting following spinal cord injury , 2009, Journal of neurochemistry.
[61] M. Murakami,et al. Mast cells mediate neutrophil recruitment and vascular leakage through the NLRP3 inflammasome in histamine-independent urticaria , 2009, The Journal of experimental medicine.
[62] P. Kubes,et al. Bone Marrow-Derived Mast Cells Accumulate in the Central Nervous System During Inflammation but Are Dispensable for Experimental Autoimmune Encephalomyelitis Pathogenesis1 , 2009, The Journal of Immunology.
[63] F. Gage,et al. A Nurr1/CoREST Pathway in Microglia and Astrocytes Protects Dopaminergic Neurons from Inflammation-Induced Death , 2009, Cell.
[64] R. Ransohoff,et al. Localizing central nervous system immune surveillance: Meningeal antigen‐presenting cells activate T cells during experimental autoimmune encephalomyelitis , 2009, Annals of neurology.
[65] Shizuo Akira,et al. The roles of TLRs, RLRs and NLRs in pathogen recognition. , 2009, International immunology.
[66] V. Perry,et al. Microglial physiology: unique stimuli, specialized responses. , 2009, Annual review of immunology.
[67] S. Barnum,et al. Transgenic Inhibition of Astroglial NF-κB Improves Functional Outcome in Experimental Autoimmune Encephalomyelitis by Suppressing Chronic Central Nervous System Inflammation1 , 2009, The Journal of Immunology.
[68] U. Zettl,et al. Animal models of multiple sclerosis for the development and validation of novel therapies – potential and limitations , 2008, Journal of Neurology.
[69] Melissa A Brown,et al. Mast Cells , 2008, Annals of the New York Academy of Sciences.
[70] M. Kurrer,et al. GM-CSF mediates autoimmunity by enhancing IL-6–dependent Th17 cell development and survival , 2008, The Journal of experimental medicine.
[71] T. Jakob,et al. Cutting Edge: Instructive Role of Peripheral Tissue Cells in the Imprinting of T Cell Homing Receptor Patterns1 , 2008, The Journal of Immunology.
[72] T. Suuronen,et al. Amyloid-β oligomers set fire to inflammasomes and induce Alzheimer's pathology , 2008, Journal of cellular and molecular medicine.
[73] P. Halloran,et al. The Puzzling Role of CXCR3 and Its Ligands in Organ Allograft Rejection , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[74] K. Moore,et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-β , 2008, Nature Immunology.
[75] T. Lane,et al. The Th17–ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune disease , 2008, The Journal of experimental medicine.
[76] V. Perry,et al. Systemic inflammation switches the inflammatory cytokine profile in CNS Wallerian degeneration , 2008, Neurobiology of Disease.
[77] B. Trapp,et al. Preconditioning paradigms and pathways in the brain. , 2008, Cleveland Clinic journal of medicine.
[78] F. Rossi,et al. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life , 2007, Nature Neuroscience.
[79] D. Cleveland,et al. Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease , 2007, Nature Neuroscience.
[80] H. Kettenmann,et al. Microglia: active sensor and versatile effector cells in the normal and pathologic brain , 2007, Nature Neuroscience.
[81] F. Martinon,et al. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration , 2007, Cell Death and Differentiation.
[82] B. Weinshenker,et al. The spectrum of neuromyelitis optica , 2007, The Lancet Neurology.
[83] F. Martinon,et al. NALP Inflammasomes: a central role in innate immunity , 2007, Seminars in Immunopathology.
[84] G. Dubyak,et al. Nonclassical IL-1β Secretion Stimulated by P2X7 Receptors Is Dependent on Inflammasome Activation and Correlated with Exosome Release in Murine Macrophages1 , 2007, The Journal of Immunology.
[85] Swati Banerjee,et al. Neuron-glial interactions in blood-brain barrier formation. , 2007, Annual review of neuroscience.
[86] Yan Ping Zhang,et al. Transgenic glial nuclear factor-kappa B inhibition decreases formalin pain in mice , 2007, Neuroreport.
[87] Colm Cunningham,et al. The sickness behaviour and CNS inflammatory mediator profile induced by systemic challenge of mice with synthetic double-stranded RNA (poly I:C) , 2007, Brain, Behavior, and Immunity.
[88] S. Miller,et al. Antigen Presentation in the CNS by Myeloid Dendritic Cells Drives Progression of Relapsing Experimental Autoimmune Encephalomyelitis , 2007, Annals of the New York Academy of Sciences.
[89] P. Sansonetti,et al. Sensing of bacteria: NOD a lonely job. , 2007, Current opinion in microbiology.
[90] D. Bonifati,et al. Role of complement in neurodegeneration and neuroinflammation. , 2007, Molecular immunology.
[91] Colm Cunningham,et al. Systemic infections and inflammation affect chronic neurodegeneration , 2007, Nature Reviews Immunology.
[92] M. Bianchi. DAMPs, PAMPs and alarmins: all we need to know about danger , 2007, Journal of leukocyte biology.
[93] S. Hauser,et al. The Neurobiology of Multiple Sclerosis: Genes, Inflammation, and Neurodegeneration , 2006, Neuron.
[94] W. Reith,et al. TGFbeta receptor II gene deletion in leucocytes prevents cerebral vasculitis in bacterial meningitis. , 2006, Brain : a journal of neurology.
[95] Steffen Jung,et al. Control of microglial neurotoxicity by the fractalkine receptor , 2006, Nature Neuroscience.
[96] S. Miller,et al. CNS dendritic cells: Critical participants in CNS inflammation? , 2006, Neurochemistry International.
[97] G. Kollias,et al. Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia , 2006, Science.
[98] S. Miller,et al. Mechanisms of Immunopathology in Murine Models of Central Nervous System Demyelinating Disease1 , 2006, The Journal of Immunology.
[99] Carl Nathan,et al. Neutrophils and immunity: challenges and opportunities , 2006, Nature Reviews Immunology.
[100] S. Gordon,et al. Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.
[101] V. Perry,et al. Central and Systemic Endotoxin Challenges Exacerbate the Local Inflammatory Response and Increase Neuronal Death during Chronic Neurodegeneration , 2005, The Journal of Neuroscience.
[102] C. Chen,et al. Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. , 2005, The American journal of pathology.
[103] E. J. Green,et al. Inhibition of astroglial nuclear factor κB reduces inflammation and improves functional recovery after spinal cord injury , 2005, The Journal of experimental medicine.
[104] P. Gasque,et al. Innate (inherent) control of brain infection, brain inflammation and brain repair: the role of microglia, astrocytes, “protective” glial stem cells and stromal ependymal cells , 2005, Brain Research Reviews.
[105] E. Kremmer,et al. Dendritic cells govern induction and reprogramming of polarized tissue‐selective homing receptor patterns of T cells: important roles for soluble factors and tissue microenvironments , 2005, European journal of immunology.
[106] B. Becher,et al. Experimental autoimmune encephalomyelitis repressed by microglial paralysis , 2005, Nature Medicine.
[107] J. Mora,et al. Reciprocal and dynamic control of CD8 T cell homing by dendritic cells from skin- and gut-associated lymphoid tissues , 2005, The Journal of experimental medicine.
[108] L. O’Neill. TLRs: Professor Mechnikov, sit on your hat. , 2004, Trends in immunology.
[109] H. Thorlacius,et al. Neutrophil recruitment in mast cell-dependent inflammation: inhibitory mechanisms of glucocorticoids , 2004, Inflammation Research.
[110] M. Minami,et al. Endotoxin Preconditioning Prevents Cellular Inflammatory Response During Ischemic Neuroprotection in Mice , 2004, Stroke.
[111] B. Rollins,et al. Differential roles of CCL2 and CCR2 in host defense to coronavirus infection , 2004, Virology.
[112] V. Perry. The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease , 2004, Brain, Behavior, and Immunity.
[113] Rongguo Yu,et al. Activation of P2 nucleotide receptors stimulates acid efflux from astrocytes , 2004, Glia.
[114] F. Martinon,et al. Inflammatory Caspases Linking an Intracellular Innate Immune System to Autoinflammatory Diseases , 2004, Cell.
[115] B. Serafini,et al. Detection of Ectopic B‐cell Follicles with Germinal Centers in the Meninges of Patients with Secondary Progressive Multiple Sclerosis , 2004, Brain pathology.
[116] R. Fujinami,et al. Distinct roles for IP-10/C XC L10 in three animal models, Theiler’s virus infection, EA E, and MHV infection, for multiple sclerosis: implication of differing roles for IP-10 , 2004, Multiple sclerosis.
[117] M. Kamoun,et al. Differential expression and regulation of IL-23 and IL-12 subunits and receptors in adult mouse microglia , 2003, Journal of the Neurological Sciences.
[118] C. Gutekunst,et al. Mast Cells Exert Effects Outside the Central Nervous System to Influence Experimental Allergic Encephalomyelitis Disease Course 1 , 2003, The Journal of Immunology.
[119] N. Gay,et al. Binding of the Drosophila cytokine Spätzle to Toll is direct and establishes signaling , 2003, Nature Immunology.
[120] C. Yiannoutsos,et al. SDF‐1α Is Expressed in Astrocytes and Neurons in the AIDS Dementia Complex: An In Vivo and In Vitro Study , 2003 .
[121] W. Kuziel,et al. CC Chemokine Ligand 3 (CCL3) Regulates CD8+-T-Cell Effector Function and Migration following Viral Infection , 2003, Journal of Virology.
[122] Jorge R. Oksenberg,et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis , 2002, Nature Medicine.
[123] R. Dantzer,et al. Interleukin-10 in the brain. , 2001, Critical reviews in immunology.
[124] W. Kuziel,et al. Lack of CCR2 Results in Increased Mortality and Impaired Leukocyte Activation and Trafficking Following Infection of the Central Nervous System with a Neurotropic Coronavirus1 , 2001, The Journal of Immunology.
[125] Denise Feighan,et al. P2X7-Like Receptor Activation in Astrocytes Increases Chemokine Monocyte Chemoattractant Protein-1 Expression via Mitogen-Activated Protein Kinase , 2001, The Journal of Neuroscience.
[126] D. Remick,et al. Early Chemokine Cascades in Murine Cardiac Grafts Regulate T Cell Recruitment and Progression of Acute Allograft Rejection1 , 2001, The Journal of Immunology.
[127] G. Kollias,et al. CXCR4-activated astrocyte glutamate release via TNFα: amplification by microglia triggers neurotoxicity , 2001, Nature Neuroscience.
[128] M. Byrne,et al. Microbial Lipopeptides Induce the Production of IL-17 in Th Cells1 , 2000, The Journal of Immunology.
[129] V. Perry,et al. Interleukin-1β-Induced Changes in Blood–Brain Barrier Permeability, Apparent Diffusion Coefficient, and Cerebral Blood Volume in the Rat Brain: A Magnetic Resonance Study , 2000, The Journal of Neuroscience.
[130] M. Buchmeier,et al. Cutting Edge: The T Cell Chemoattractant IFN-Inducible Protein 10 Is Essential in Host Defense Against Viral-Induced Neurologic Disease1 , 2000, The Journal of Immunology.
[131] L. Weiner,et al. Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor , 2000, Neurology.
[132] C. Gutekunst,et al. Mast Cells Are Essential for Early Onset and Severe Disease in a Murine Model of Multiple Sclerosis , 2000, The Journal of experimental medicine.
[133] S. McColl,et al. Treatment with anti-granulocyte antibodies inhibits the effector phase of experimental autoimmune encephalomyelitis. , 1998, Journal of immunology.
[134] Michael Schroeter,et al. Inflammation and glial responses in ischemic brain lesions , 1998, Progress in Neurobiology.
[135] J. Määttä,et al. Neutrophils secreting tumor necrosis factor alpha infiltrate the central nervous system of BALB/c mice with experimental autoimmune encephalomyelitis , 1998, Journal of Neuroimmunology.
[136] W. Streit,et al. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[137] D. Irani. Brain-derived gangliosides induce cell cycle arrest in a murine T cell line , 1998, Journal of Neuroimmunology.
[138] E. Major,et al. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[139] D. Griffin,et al. Brain-derived gangliosides regulate the cytokine production and proliferation of activated T cells. , 1996, Journal of immunology.
[140] A. Reder,et al. The mast cells of the multiple sclerosis brain , 1996, Journal of Neuroimmunology.
[141] S. Majumder,et al. Transcriptional regulation of chemokine gene expression in astrocytes , 1996, Journal of neuroscience research.
[142] R. Ransohoff,et al. Chemokine monocyte chemoattractant protein-1 is expressed by astrocytes after mechanical injury to the brain. , 1996, Journal of immunology.
[143] S. Abraham,et al. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α , 1996, Nature.
[144] S. Hauser,et al. Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients , 1995, Annals of neurology.
[145] Roland Martin,et al. Myelin basic protein‐specific T‐cell responses in identical twins discordant or concordant for multiple sclerosis , 1993, Annals of neurology.
[146] R. Ransohoff,et al. Astrocyte expression of mRNA encoding cytokines IP‐10 and JE/MCP‐1 in experimental autoimmune encephalomyelitis , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[147] S. Galli,et al. Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell- deficient W/Wv mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells , 1985, The Journal of experimental medicine.
[148] L. Tuomisto,et al. Histamine and histamine-N-methyltransferase in the CSF of patients with multiple sclerosis , 1983, Agents and Actions.
[149] D. J. Neumann. Ueber das Vorkommen der sogenannten „Mastzellen” bei pathologischen Veränderungen des Gehirns , 1890, Archiv für pathologische Anatomie und Physiologie und für klinische Medicin.
[150] B. Castellano,et al. Antigen presentation in EAE: role of microglia, macrophages and dendritic cells. , 2011, Frontiers in bioscience.
[151] Ping Han 韩萍,et al. Research progress on interleukin-33 and its roles in the central nervous system , 2011, Neuroscience Bulletin.
[152] D. Hafler,et al. T-cells in multiple sclerosis. , 2010, Results and problems in cell differentiation.
[153] A. Planas,et al. Astrocytes are very sensitive to develop innate immune responses to lipid‐carried short interfering RNA , 2009, Glia.
[154] V. Perry,et al. What is immune privilege (not)? , 2007, Trends in immunology.
[155] R. Reynolds,et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. , 2007, Brain : a journal of neurology.
[156] A. Volterra,et al. Glutamate release from astrocytes in physiological conditions and in neurodegenerative disorders characterized by neuroinflammation. , 2007, International review of neurobiology.
[157] C. Yiannoutsos,et al. SDF-1alpha is expressed in astrocytes and neurons in the AIDS dementia complex: an in vivo and in vitro study. , 2003, Journal of neuropathology and experimental neurology.
[158] I. Bechmann,et al. Self-tolerance in the immune privileged CNS: lessons from the entorhinal cortex lesion model. , 2003, Journal of neural transmission. Supplementum.
[159] R. Hohlfeld,et al. T-cell-mediated autoimmunity: novel techniques to characterize autoreactive T-cell receptors. , 2003, The American journal of pathology.
[160] J. Tekstra,et al. Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions. , 1999, The American journal of pathology.
[161] R. Ransohoff,et al. Murine experimental autoimmune encephalomyelitis: a model of immune-mediated inflammation and multiple sclerosis. , 1997, Methods in enzymology.
[162] R. Ransohoff,et al. [13] Murine experimental autoimmune encephalomyelitis: A model of immune-mediated inflammation and multiple sclerosis , 1997 .